This is a routine administrative filing with no actionable trading signal. Monitor upcoming H1 2026 earnings release for financial performance updates.
Price Chart
Executive Summary
Genmab A/S filed its updated Articles of Association on August 11, 2026, via a Form 6-K on August 12, 2026. The filing is a routine corporate governance update, renewing existing authorizations for the Board of Directors to issue shares and warrants for employee incentive programs through March 2029/2030. The document details the terms of employee warrant schemes, including vesting schedules and exercise prices. No material financial data, changes in business operations, or new strategic initiatives were disclosed. The filing is administrative in nature and does not contain information that would materially impact the company's stock price.
Key Facts
- Genmab filed an updated set of Articles of Association on August 11, 2026.
- The Board of Directors' authorization to increase share capital without pre-emption rights (up to DKK 6.6M) is renewed through March 12, 2029.
- The Board of Directors' authorization to issue convertible debt instruments (up to DKK 3M nominal) is renewed through March 12, 2029.
- Multiple employee warrant schemes are detailed, with grants issued from 2017 through June 2026, all with exercise prices at or above market price at time of grant.
- The filing is a routine corporate governance update with no financial results or operational changes.
Financial Impact
No financial impact. The filing is a routine update of corporate governance documents with no new financial data.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (GMAB) — Batch item 1 | 0001434265-26-000113 |
| Document: gmab_20260812x6k.htm | 0001434265-26-000113 |
| Document: 0001434265-26-000113-index-headers.html | 0001434265-26-000113 |
| Document: 0001434265-26-000113-index.html | 0001434265-26-000113 |
| Document: 0001434265-26-000113.txt | 0001434265-26-000113 |
| 6-K Filing (GMAB) — Batch item 6 | 0001434265-26-000113 |
| Document: gmab_20260812x6k.htm | 0001434265-26-000113 |
| Document: 0001434265-26-000113-index-headers.html | 0001434265-26-000113 |
| Document: 0001434265-26-000113-index.html | 0001434265-26-000113 |
| Document: 0001434265-26-000113.txt | 0001434265-26-000113 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 8, 2026 24d ago | 6-K | $33.53 $32.65 | ▼ −2.62% | ▼ −1.96% | $34.51 (+2.94%) |
Aug 12, 2026 7w ago | 6-K | $31.42 $34.11 | ▲ +8.56% | ▲ +9.01% | $34.51 (+9.85%) |
Aug 11, 2026 7w ago | 6-K | $30.85 $32.96 | ▲ +6.84% | ▲ +7.24% | $34.51 (+11.88%) |
Aug 6, 2026 8w ago | 6-K | $29.83 $31.34 | ▲ +5.06% | ▲ +3.85% | $34.51 (+15.71%) |
Jul 15, 2026 11w ago | 6-K | $29.08 $28.85 | ▼ −0.79% | ▲ +0.19% | $34.51 (+18.69%) |
Jun 29, 2026 13w ago | 6-K | $27.47 $28.01 | ▲ +1.97% | ▲ +1.36% | $34.51 (+25.65%) |
Jun 17, 2026 15w ago | 6-K | $25.39 $25.87 | ▲ +1.87% | ▲ +2.91% | $34.51 (+35.94%) |
Jun 16, 2026 15w ago | 6-K | $24.74 $25.94 | ▲ +4.85% | ▲ +7.08% | $34.51 (+39.51%) |
Jun 15, 2026 15w ago | 6-K | $24.58 $25.61 | ▲ +4.19% | ▲ +5.57% | $34.51 (+40.42%) |
Jun 15, 2026 15w ago | 6-K | $24.58 $25.61 | ▲ +4.19% | ▲ +5.57% | $34.51 (+40.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access